Lymphoma

11 currently open clinical trials

Alternative chemotherapy regimen for patients with Hodgkin lymphoma
HD 21
Mediastinal radiotherapy after rituximab-containing chemotherapy regimens to patients with large B-Cell Lymphoma
IELSG-37
Improving treatment outcomes in mantle cell lymphoma
TRIANGLE
Optimization of chemotherapy for Burkitt lymphoma
HOVON 127/ SAKK 37/16
Combined therapy for mantle cell lymphoma
SAKK 36/13
Safety and tolerability of a combination of obinutuzumab and venetoclax in patients with advanced follicular lymphoma
SAKK 35/15
Treatment of follicular lymphoma with rituximab and ibrutinib
SAKK 35/14
Pomalidomide on alternate days in patients with refractory multiple myeloma
SAKK 39/16 OptiPOM
High-dose chemotherapy and autologous stem cell transplant consolidating conventional chemotherapy in primary CNS lymphoma -randomized phase III trial (Matrix)
IELSG-43
An international phase II trial assessing tolerability and efficacy of sequential Methotrexate-Aracytin-based combination and R-ICE combination followed by high-dose chemotherapy supported by autologous stem cell transplant in patients with systemic DLBCL
IELSG-42
Studie mit dem ATR Inhibitor BAY-1895344 bei Patienten mit fortgeschrittenen soliden Tumoren und Lymphomen (Erstanwendung beim Menschen)
SAKK 69/17
All cancer types